Introduction
TYPE 1 DIABETES
Self-monitoring of glucose levels, whether by self-monitored capillary blood glucose (SMBG), real-time continuous glucose monitoring (rtCGM), or intermittently scanned continuous glucose monitoring [isCGM]), is strongly recommended for children with type 1 diabetes (T1D).When compared with first-generation isCGM, rtCGM systems are superior in terms of glucose control, specifically time in range (TIR) and glycated hemoglobin (HbA1c).However, in children aged 4–13 years, there are no published randomized controlled trials (RCTs) on either first- or second-generation isCGM. These data are required, as when compared with adult data, pediatric technology outcomes are not always comparable.